ACA5: Decision making in dementia
Lead Research Organisation:
MRC Cognition and Brain Sciences Unit
Abstract
How do you decide what to do, what action to take? Many patients with brain damage, Parkinson’s disease or dementia have difficulty making every day decisions about what to do, in the right place or at the right time. Patients may also have difficulty with mental flexibility, required to do different things when circumstances change, or to stop oneself when needed.
Our research group uses brain scanning and new methods in computer science and psychology to understand how healthy people and those with brain illnesses make decisions about what to do, and what not to do.
These decisions are made possible by the flow of information through brain networks. We use MRI and MEG type brain scanners to study these networks, in health, over the lifespan, and in people with emerging dementia.
Our research group uses brain scanning and new methods in computer science and psychology to understand how healthy people and those with brain illnesses make decisions about what to do, and what not to do.
These decisions are made possible by the flow of information through brain networks. We use MRI and MEG type brain scanners to study these networks, in health, over the lifespan, and in people with emerging dementia.
Technical Summary
Advances in new treatments for dementia require a new mechanistic understanding of disease, linking changes in cognitive function to underlying neural systems and their pharmacology. They also require new tools to identify the signatures of nascent pathology in (as yet) asymptomatic patients that can be used to safely and reliably track the emergence of disease in the context of preventive and therapeutic clinical trials.
In the first part of this program, we develop new models of cognitive function, based neurophysiological models of decision making circuits. We examine decisions about behavioural control (including response inhibition), volition and the perception of environmental cues that guide actions. Using accumulation-to-threshold models of perception and behaviour, we will determine the processes by which sensory inputs are transformed to motor outputs, and the vulnerability of these processes to two different disorders: Parkinson’s disease and Alzheimer’s disease.
In the second part of the program, we will examine the problem that some people have increasingly poor cognitive function with age. This may be the presence of subclinical dementias, and we will compare neural signatures in healthy older adults to those with early dementia. However, unsuccessful cognitive ageing is not necessarily just a matter of early dementia.
Even those without emerging dementia will vary in their cognitive ageing profile, for reasons that we will elucidate. This builds on the CamCAN study of healthy ageing, bringing in for the first time those adults who performed poorly on screening tests. We will apply a tailored battery of imaging and psychological assessments, using MRI, fMRI and MEG, and use supervised machine earning methods to identify the neural factors that are associated with poor function. These will be compared with neural factors associated with early AD.
This program links directly to the Cambridge Centre for Ageing and Neuroscience (CamCAN) and the Dementias Platform UK, both in terms of the Synaptic Health Theme for Experimental Medicines, and the Deep and Frequent Phenotyping study of prodromal dementia. The MRC “ACA5. Decision making in dementia” provides vital links between normative studies, ageing and neurodegeneration. Through my Wellcome Trust Senior Research Fellowship and the NIHR Biomedical Research Centre’s Neurodegeneration and dementia theme we are developing pharmacological interventions to restore cognition, with direct translation from ACA5 innovations to clinical populations.
In the first part of this program, we develop new models of cognitive function, based neurophysiological models of decision making circuits. We examine decisions about behavioural control (including response inhibition), volition and the perception of environmental cues that guide actions. Using accumulation-to-threshold models of perception and behaviour, we will determine the processes by which sensory inputs are transformed to motor outputs, and the vulnerability of these processes to two different disorders: Parkinson’s disease and Alzheimer’s disease.
In the second part of the program, we will examine the problem that some people have increasingly poor cognitive function with age. This may be the presence of subclinical dementias, and we will compare neural signatures in healthy older adults to those with early dementia. However, unsuccessful cognitive ageing is not necessarily just a matter of early dementia.
Even those without emerging dementia will vary in their cognitive ageing profile, for reasons that we will elucidate. This builds on the CamCAN study of healthy ageing, bringing in for the first time those adults who performed poorly on screening tests. We will apply a tailored battery of imaging and psychological assessments, using MRI, fMRI and MEG, and use supervised machine earning methods to identify the neural factors that are associated with poor function. These will be compared with neural factors associated with early AD.
This program links directly to the Cambridge Centre for Ageing and Neuroscience (CamCAN) and the Dementias Platform UK, both in terms of the Synaptic Health Theme for Experimental Medicines, and the Deep and Frequent Phenotyping study of prodromal dementia. The MRC “ACA5. Decision making in dementia” provides vital links between normative studies, ageing and neurodegeneration. Through my Wellcome Trust Senior Research Fellowship and the NIHR Biomedical Research Centre’s Neurodegeneration and dementia theme we are developing pharmacological interventions to restore cognition, with direct translation from ACA5 innovations to clinical populations.
Organisations
- MRC Cognition and Brain Sciences Unit, United Kingdom (Lead Research Organisation)
- University College London, United Kingdom (Collaboration)
- EU Joint Programme - Neurodegenerative Disease Research (JPND) (Collaboration)
- Newcastle University, United Kingdom (Collaboration)
- Swedish Research Council (Collaboration)
- Janssen Biotech, Inc. (Collaboration)
- University of Cambridge (Collaboration)
- Cardiff University, United Kingdom (Collaboration)
- AstraZeneca plc (Collaboration)
- Siemens Healthcare (Collaboration)
- University of Nottingham (Collaboration)
- University of Oxford, United Kingdom (Collaboration)
- National Institute for Health Research, United Kingdom (Collaboration)
- Alzheimer's Research Uk (Collaboration)
- Eli Lilly & Company Ltd (Collaboration)
- Imperial College London, United Kingdom (Collaboration)
- MRC Dementias Platform UK (Collaboration)
- University of Glasgow, United Kingdom (Collaboration)
- Progressive Supranuclear Palsy Association (PSPA) (Collaboration)
- University of East Anglia, United Kingdom (Collaboration)
- Medical Research Council (Collaboration)
- University of Exeter, United Kingdom (Collaboration)
- University of Manchester, Manchester, United Kingdom (Collaboration)
- Addenbrooke's Hospital (Collaboration)
- King's College London, United Kingdom (Collaboration)
People |
ORCID iD |
James B Rowe (Principal Investigator) |
Publications

Adams NE
(2021)
GABAergic cortical network physiology in frontotemporal lobar degeneration.
in Brain : a journal of neurology

Adams NE
(2020)
GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.
in The Journal of neuroscience : the official journal of the Society for Neuroscience

Alexander SK
(2014)
Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.
in Journal of neurology, neurosurgery, and psychiatry

Beck J
(2013)
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.
in American journal of human genetics

Berry E
(2009)
The neural basis of effective memory therapy in a patient with limbic encephalitis.
in Journal of neurology, neurosurgery, and psychiatry

Bevan Jones WR
(2016)
[18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation.
in Annals of clinical and translational neurology

Bevan-Jones RW
(2018)
[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion.
in Annals of clinical and translational neurology



Bevan-Jones WR
(2018)
[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia.
in Journal of neurology, neurosurgery, and psychiatry
Title | MEG & ME |
Description | With ISSF funding, out team held a series of public open evenings to discuss research of interest to the public, to define a sho set of questions and design the experiments to answer them, and then carry it out using MEG. The project was filmed, and presented at a final public discussion meeting at the Cambridge Science Festival |
Type Of Art | Film/Video/Animation |
Year Produced | 2015 |
Impact | The project clearly caught he public's imagination, and over 100 members of the public took part across the weeks. https://vimeo.com/116423919 presents a final summary video |
URL | https://vimeo.com/116423919 |
Title | Misplaced in Space (September 2017) |
Description | A collaboration with University of East Anglia, to portray the impact of Dementia |
Type Of Art | Artistic/Creative Exhibition |
Year Produced | 2017 |
Impact | A film of the exhibition is available; |
URL | https://vimeo.com/229381641 |
Title | Pint of Science |
Description | Pint of Science festival presentations in pubs, bringing research progress and ideas to the public. |
Type Of Art | Performance (Music, Dance, Drama, etc) |
Year Produced | 2018 |
Impact | Wide public interest -sell out events |
Description | AI-MIND Consortium SAB |
Geographic Reach | Europe |
Policy Influence Type | Participation in a advisory committee |
Impact | The AI-MIND Consortium is to delivery new artificial intelligence methods to improve diagnosis and prognosis in dementia |
URL | https://accelopment.com/projects/ai-mind/ |
Description | Acadamey of Medical Sciences review of research governance |
Geographic Reach | National |
Policy Influence Type | Participation in a national consultation |
Impact | Description of experience of current unnecessary obstacles to safe clinical research and observations on practicable solutions. |
Description | Alzheimer Research UK Scientific Advisory Board Chair |
Geographic Reach | National |
Policy Influence Type | Participation in a advisory committee |
Impact | To ensure the £30m annual investment in dementia research is most effective, for long term health, social and economic benefit |
Description | Cabinet briefing meeting - dementia |
Geographic Reach | National |
Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
Impact | enhanced care and research progress on dementia |
Description | Cambridge Dementia Course |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
URL | http://www.cambridgedementiacourse.com/index.html |
Description | Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria (May 2017). |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Influenced training of practitioners or researchers |
URL | https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.26987 |
Description | DPUK2Associate Director |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | DPUK is leading academic-industrial partnerships for dementia research, and coordinating the 'ecosystem' for dementia research and care in the UK. As associate Director and lead for Experimental Medicine, my role is to accelerate early phase clinical trials though partnerships with industry, academic and third-sector stakeholder collaborations |
URL | https://www.dementiasplatform.uk/ |
Description | Dr M Malpetti - Invited contribution to the World Alzheimer Report 2021 |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Publication to serve as reference for students and practitioners. |
URL | https://www.alzint.org/u/World-Alzheimer-Report-2021.pdf |
Description | Education - postdoctoral and graduate level |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Education of nationally distributed participants in conferences for "neurology for neuroscientists" and "advances in neuroscience", related to PD and other related neurodegenrative syndromes; Dementia care and management; |
Description | Invited abstract reviewing board member at Tau2022 conference - Dr M Malpetti |
Geographic Reach | Europe |
Policy Influence Type | Membership of a guideline committee |
Impact | Served as subject specific reviewer. |
Description | Invited abstract reviewing board member at the European Molecular Imaging Meeting - Dr M Malpetti |
Geographic Reach | Europe |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Served as subject specific reviewer. |
Description | Invited co-authorship for a systematic review - Dr M Malpetti |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Contribution to new or Improved professional practice |
Impact | Publication in a major journal. |
Description | Invited contribution to hot-topic series for the Journal of Nuclear Medicine - Dr M Malpetti |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Contribution to new or Improved professional practice |
Description | Memory Assessment Services |
Geographic Reach | National |
Policy Influence Type | Participation in a national consultation |
Impact | A discussion and proposal on adaptation of Memory Services to COVID, and the adoption of Telemedicine, with safety, equality of access, and forward planning for post COVID |
URL | http://www.yhscn.nhs.uk/media/PDFs/mhdn/Dementia/Covid%2019/MAS/MSA%20-%20A%20New%20Way%20of%20Worki... |
Description | Models and standards of Care (PSP) |
Geographic Reach | National |
Policy Influence Type | Membership of a guideline committee |
Impact | New guidelines on standards of care, including opportunities to engage in research, for patients with PSP and CBD. |
Description | NIHT Translational Research Collaboration for dementia |
Geographic Reach | National |
Policy Influence Type | Participation in a advisory committee |
Impact | To facilitate multilateral research across academic, healthcare and industrial partners in the UK, for better and faster dementia research. Reports to NIHR Office for Clinical Research Infrastructure (NOCRI) |
URL | https://www.nihr.ac.uk/partners-and-industry/industry/collaborate-with-us/dementia.htm |
Description | NMHB member |
Geographic Reach | National |
Policy Influence Type | Participation in advisory committee |
Impact | MRC Neuroscience and Mental Health Strategy review Oct 2012, Brain Banking Workshop 2013, Dementia Stigma 2014 |
Description | PSP Criteria |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Membership of a guideline committee |
Impact | The new evidence-based criteria include the importance of cognitive presentations in PSP, in part to improve access to trials, and in part to improve sensitivity and specificity of criteria. Much of the background work was undertaken at CBSU |
Description | Rowe - Masterclass (23rd March 2018). Danish Dementia Research Centre, Copenhagen, Denmark |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Masterclass in front of practitioners. Ad hoc patient review as training. |
Description | Trond Mohn Foundation |
Geographic Reach | Europe |
Policy Influence Type | Participation in a advisory committee |
Impact | Advisory committee for a major biomedical research foundation |
Description | UHF Research Review in Parkinsonism |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Citation in systematic reviews |
Description | US congressinal delegation |
Geographic Reach | North America |
Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
Description | A new noradrenergic strategy for treatment of PSP |
Amount | £653,896 (GBP) |
Funding ID | MR/P01271X/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2017 |
End | 03/2020 |
Description | A standardized, multilingual, mini linguistic state examination (MLSE) for classifying and monitoring primary progressive aphasia. |
Amount | £358,924 (GBP) |
Funding ID | RG82683 |
Organisation | St George's University |
Sector | Academic/University |
Country | Grenada |
Start | 01/2017 |
End | 12/2019 |
Description | ABN Research Fellowship (Cope) |
Amount | £180,000 (GBP) |
Funding ID | RG78594 |
Organisation | Association of British Neurologists (ABN) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2015 |
End | 11/2018 |
Description | ABN fellowship to Thomas Cope |
Amount | £179,988 (GBP) |
Organisation | Association of British Neurologists (ABN) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2016 |
End | 12/2018 |
Description | ARUK - Cambridge Network Centre |
Amount | £4,000 (GBP) |
Funding ID | RG86800 |
Organisation | Versus Arthritis |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2016 |
End | 08/2017 |
Description | Biomedical Research Centre Dementia Theme |
Amount | £118,000,000 (GBP) |
Funding ID | RG85367 |
Organisation | National Institute for Health Research |
Department | NIHR Biomedical Research Centre |
Sector | Public |
Country | United Kingdom |
Start | 03/2017 |
End | 03/2022 |
Description | Bioresource |
Amount | £272,205 (GBP) |
Funding ID | RG85445 |
Organisation | National Institute for Health Research |
Sector | Public |
Country | United Kingdom |
Start | 03/2017 |
End | 03/2018 |
Description | Brain Network Analysis in Neurodegenerative Tauopathies |
Amount | £22,391 (GBP) |
Funding ID | RG89925 |
Organisation | The Evelyn Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2018 |
End | 12/2019 |
Description | Cam-Can |
Amount | £310,000 (GBP) |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2010 |
End | 10/2015 |
Description | Clinical research infrastructure |
Amount | £6,995,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 08/2015 |
End | 09/2020 |
Description | Elucidating the mechanisms of psychosis in motor neuron disease - to Alicia Wilcox |
Amount | £108,693 (GBP) |
Funding ID | RG87714 |
Organisation | Versus Arthritis |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2017 |
End | 09/2020 |
Description | GENetic Frontotemporal dementia Imaging - Second phase (GENFI-2) |
Amount | £2,613,582 (GBP) |
Funding ID | MR/M023664/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 04/2015 |
End | 04/2020 |
Description | Inflammation in frontotemporal lobar degeneration - from diagnosis and prognosis to clinical trials - Dr M Malpetti |
Amount | £495,687 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2022 |
End | 02/2027 |
Description | JPND EUFIND |
Amount | £30,000 (GBP) |
Organisation | EU Joint Programme - Neurodegenerative Disease Research (JPND) |
Sector | Public |
Country | European Union (EU) |
Start | 09/2016 |
End | 10/2017 |
Description | Linking patient phenotype with cell and animal models of alpha-synucleinopathies and tauopathy to study disease pathogenesis and biomarker candidates |
Amount | £1,300,000 (GBP) |
Funding ID | RG75814 |
Organisation | AstraZeneca |
Department | MedImmune |
Sector | Private |
Country | United Kingdom |
Start | 09/2014 |
End | 08/2018 |
Description | MAPT-PSP: clinicopathological correlations and biomarker evaluation of a tau radioligand in progressive supranuclear palsy in preparation for clinical trials |
Amount | £93,105 (GBP) |
Funding ID | RG76137 |
Organisation | Progressive Supranuclear Palsy Association (PSPA) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 11/2014 |
End | 12/2016 |
Description | MRC Partnership grant for UK7T |
Amount | £220,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2016 |
End | 03/2019 |
Description | MRC clinical training fellowship |
Amount | £275,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2011 |
End | 10/2014 |
Description | MRC clinical training fellowship |
Amount | £272,739 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2007 |
End | 10/2010 |
Description | Measuring microscopic changes at the macroscopic level in frontotemporal dementia - Fellowship to Sanne S. Kaalund |
Amount | 400,000 kr. (DKK) |
Funding ID | R232-2016-2333 |
Organisation | Lundbeck Foundation |
Sector | Charity/Non Profit |
Country | Denmark |
Start | 07/2017 |
End | 07/2019 |
Description | Multi-scale network dynamics of the ageing brain: Modelling neurocognitive function and dysfunction - Fellowship to Kamen Tsvetanov |
Amount | £264,375 (GBP) |
Funding ID | RG84427 |
Organisation | The British Academy |
Sector | Academic/University |
Country | United Kingdom |
Start | 01/2017 |
End | 12/2019 |
Description | NIHR BRU-dementia |
Amount | £600,000 (GBP) |
Organisation | National Institute for Health Research |
Department | NIHR Cambridge Biomedical Research Centre |
Sector | Academic/University |
Country | United Kingdom |
Start | 03/2012 |
End | 03/2017 |
Description | NIHR Biomedical Research Centre |
Amount | £250,000 (GBP) |
Organisation | National Institute for Health Research |
Department | NIHR Cambridge Biomedical Research Centre |
Sector | Academic/University |
Country | United Kingdom |
Start | 03/2012 |
End | 03/2017 |
Description | New Therapeutics in Alzheimer s Disease (NTAD) - ARUK |
Amount | £100,000 (GBP) |
Funding ID | RG89702 |
Organisation | Versus Arthritis |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2017 |
End | 08/2020 |
Description | PROSPECT-MR: magnetic resonance imaging in the longitudinal clinical and biomarker study of Progressive Supranuclear Palsy and corticobasal degeneration |
Amount | £299,995 (GBP) |
Funding ID | RG78738 |
Organisation | Progressive Supranuclear Palsy Association (PSPA) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2016 |
End | 08/2019 |
Description | PSP association |
Amount | £93,000 (GBP) |
Organisation | Progressive Supranuclear Palsy Association (PSPA) |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2015 |
End | 07/2016 |
Description | Progress in understanding volition |
Amount | $600,000 (USD) |
Funding ID | RG63965 |
Organisation | James S. McDonnell Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 12/2011 |
End | 11/2019 |
Description | Restoring noradrenergic function to improve apathy in Parkinson s disease to Claire O Callaghan |
Amount | £49,677 (GBP) |
Funding ID | RG90797 |
Organisation | Parkinson's UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 07/2017 |
End | 07/2018 |
Description | The physiology of dementia: magnetoencephalographic investigation of brain networks in frontotemporal lobar degeneration and Alzheimer's disease in preparation for experimental medicine studies. |
Amount | £49,592 (GBP) |
Funding ID | RG84879 |
Organisation | Versus Arthritis |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2016 |
End | 09/2017 |
Description | Wellcome Trust Senior Fellowship |
Amount | £1,200,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2009 |
End | 11/2014 |
Description | Wellcome Trust Senior Fellowship - Restoring brain function: from cortisol microcircuits to complex behaviours in neurodegenerative disease |
Amount | £1,885,182 (GBP) |
Funding ID | RG73750 |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2014 |
End | 11/2019 |
Title | Accumulator models and brain imaging |
Description | Demostrating and promoting the value of accumulator models in brain and behaviour analysis |
Type Of Material | Model of mechanisms or symptoms - human |
Year Produced | 2011 |
Provided To Others? | Yes |
Impact | Key papers and conference presentations in leading journals and reviews |
Title | MEG-dementia platform |
Description | MEG program for dementia and degeneration, based at CBSU Incorporated into DPUK programs |
Type Of Material | Physiological assessment or outcome measure |
Year Produced | 2015 |
Provided To Others? | Yes |
Impact | 1. innovations published in peer review journals 2. incorporated into national dementia study protocol 3. new drug discovery/evaluation program initiated |
Title | iElectrodes toolbox: for invasive electroencephalography (EEG) recordings |
Description | The localization of intracranial electrodes is a fundamental step in the analysis of invasive electroencephalography (EEG) recordings in research and clinical practice. The conclusions reached from the analysis of these recordings rely on the accuracy of electrode localization in relationship to brain anatomy. However, currently available techniques for localizing electrodes from magnetic resonance (MR) and/or computerized tomography (CT) images are time consuming and/or limited to particular electrode types or shapes. We present iElectrodes, an open-source toolbox that provides robust and accurate semi-automatic localization of both subdural grids and depth electrodes. |
Type Of Material | Model of mechanisms or symptoms - human |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | The software project is made available to the scientific community in the form of an open-source MATLAB® toolbox that can be freely downloaded from https://sourceforge.net/projects/ielectrodes/ for research porpoises only under GNU General Public License. |
URL | https://sourceforge.net/projects/ielectrodes/ |
Title | network modeling of neuroimaging data |
Description | Implementation of several methods to study brain network connectivity in humans, including patients, to understand the impact of disease and mechanism of effective therapies. |
Type Of Material | Model of mechanisms or symptoms - human |
Year Produced | 2010 |
Provided To Others? | Yes |
Impact | Interest in adopting these methods to other projects at other sites, and invitiations to teach at several centres and to publish review articles on this topic. |
Title | Cam-CAN |
Description | Cam-CAN project extended to include subarm of "Cam-CAn Frail" and early dementia participants. |
Type Of Material | Database/Collection of data |
Year Produced | 2016 |
Provided To Others? | Yes |
Impact | Extensive applications for data from CC700; Cam-CAN-Frail still in data acquisition phase. |
Title | DPUK 7T data sharing |
Description | Agreement on data sharing for 7T images using DPUK XNAT platform |
Type Of Material | Database/Collection of data |
Year Produced | 2016 |
Provided To Others? | Yes |
Impact | pending |
Description | ASAP SynTau: Alignment and Standardization of Neuroimaging Methods in Atypical Parkinsonism, specifically Synucleinopathies and Tauopathie |
Organisation | EU Joint Programme - Neurodegenerative Disease Research (JPND) |
Country | European Union (EU) |
Sector | Public |
PI Contribution | This Working Group brings together neuroimaging experts from all over the world to develop a broad, community-based consensus on imaging protocols. These outcomes will help pave the way for the integration of neuroimaging in large and longitudinal multi-centre studies in AP, including therapeutic trials. Meetings, harmonisation of imaging data, workshops, and later data sharing. |
Collaborator Contribution | Meetings, harmonisation of imaging data, workshops, and later data sharing. |
Impact | A project initiation report is submitted to JPND. Data sharing agreements are in progress. |
Start Year | 2016 |
Description | Bayesian integration of intentions, actions, and sensation. |
Organisation | University of Cambridge |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Framing the translational research question, training and supervising research students, organising and supervising the use of MRC panel members, occulography and behavioural testing. |
Collaborator Contribution | Expertise in Bayesian modeling of behaviour; Gates Scholarship student; |
Impact | Multiple abstracts to international meetings; Key papers published; This is an multi-disciplinary project, including Departments of Engineering (Cambridge) and Clinical Neurosciences; doi: 10.3389/fnins.2014.00069; doi: 10.3389/fnbeh.2014.00232; doi: 10.1523/JNEUROSCI.3093-13.2015; doi: 10.1523/JNEUROSCI.5095-14.2015; doi: 10.3389/fpsyg.2015.01514; doi: 10.1093/brain/awv331; doi: 10.1186/s12918-017-0484-3; |
Start Year | 2010 |
Description | BioFIND - JPND |
Organisation | EU Joint Programme - Neurodegenerative Disease Research (JPND) |
Country | European Union (EU) |
Sector | Public |
PI Contribution | We led the JPND award on the use of MEG in harmonisation and standarisation for Dementia research, bringing together Pharma and Academic partners from ten sites. |
Collaborator Contribution | Expertise, knowledge sharing, and scoping of future project needs. |
Impact | A project initiation report is submitted. A new data sharing project has begun across six sites. |
Start Year | 2016 |
Description | CSF biomarkers |
Organisation | Swedish Research Council |
Country | Sweden |
Sector | Public |
PI Contribution | A new collabortion for CSF biomarkers studies |
Collaborator Contribution | Biosamples and clinical metadata |
Impact | Interdisciplinary - dementia and biochemistry |
Start Year | 2015 |
Description | Cam-CAN |
Organisation | University of Cambridge |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Design and analysis of response control and inhibition studies, for fMRI and MEG. Started a new arm in 2015 called the Cam-CAN Frail study. |
Collaborator Contribution | A strong collaboration for epidemiologically validated ageing research, across multiple modalities. |
Impact | doi: 10.1186/s12883-014-0204-1; doi: 10.1038/ncomms6658; doi: 10.1002/hbm.22768; doi: 10.1016/j.neurobiolaging.2015.07.028; doi: 10.3390/ijerph121215003; doi: 10.1523/JNEUROSCI.2733-15.2016; doi: 10.1016/j.cortex.2016.05.001; doi: 10.1038/srep32527; doi: 10.1038/ncomms13034; doi: 10.1038/ncomms14743; doi: 10.1038/ncomms15671; more publications to come; |
Start Year | 2010 |
Description | Cambridge 7T consortium |
Organisation | Medical Research Council (MRC) |
Department | MRC Cognition and Brain Sciences Unit |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Forming the new University-MRC partnership and Cambridge 7T consortium. Full access to new facility for both partners. |
Collaborator Contribution | Staff allocation for physics support and adjunctive technologies for participant interaction. |
Impact | Multidisciplinary - dementia, neurology, psychiatry, development and ageing, cognitive neuroscience and physics. New head of 7T department has been recruited. |
Start Year | 2015 |
Description | Cambridge Parkinson s Disease Consortium |
Organisation | Addenbrooke's Hospital |
Country | United Kingdom |
Sector | Hospitals |
PI Contribution | Research design, recruitment, governance administration, data acquisition, analysis of behaviorual and imaging data, evaluation and publication of research. |
Collaborator Contribution | Planning of joint research projects, especially cognitive disorders in Parkinson's disease and related diseases, including several experimental medicine studies of new agents. Consolidation of collaborative partnerships, facilitating ACA5, and adding value through parallel research programs. |
Impact | Clinical and non-clinical scientists; abstracts and publications see separate entry; |
Start Year | 2009 |
Description | Cambridge Parkinson s Disease Consortium |
Organisation | University of Cambridge |
Department | Department of Psychology |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Research design, recruitment, governance administration, data acquisition, analysis of behaviorual and imaging data, evaluation and publication of research. |
Collaborator Contribution | Planning of joint research projects, especially cognitive disorders in Parkinson's disease and related diseases, including several experimental medicine studies of new agents. Consolidation of collaborative partnerships, facilitating ACA5, and adding value through parallel research programs. |
Impact | Clinical and non-clinical scientists; abstracts and publications see separate entry; |
Start Year | 2009 |
Description | Claire O Callaghan - Restoring noradrenergic function to improve apathy in Parkinson s disease |
Organisation | University of Cambridge |
Department | Department of Psychiatry |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Input on study design |
Collaborator Contribution | Study design, will do data collection and analyses, publications pending |
Impact | publications still pending |
Start Year | 2017 |
Description | Collaboration with Dr Ece Kocagoncu for NTAD (Dr A Jafarian) |
Organisation | University of Cambridge |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Collaboration on data analysis of test-retest data from NTAD. |
Collaborator Contribution | Availability of NTAD data. |
Impact | Title: Test-reTest reliability of dynamic casual modelling of resting states MEG data of Alzheimer patients. |
Start Year | 2022 |
Description | Dementias Platform UK |
Organisation | National Institute for Health Research |
Department | Biomedical Research Centre for Mental Health and Dementia Unit (BRC/U) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Deep and Frequent Phenotyping study site Synaptic Physiology Theme lead, linked to CBSU MEG and dementia programs Imaging Theme - linked to 7T and PET for dementia |
Collaborator Contribution | new deep phenotyping study - multiple modalities £1000000 offered by DPUK partners towards new collaborative award, Decision pending. |
Impact | commenced 2014 |
Start Year | 2014 |
Description | FTD neuroimaging |
Organisation | University of Cambridge |
Department | Department of Clinical Neurosciences |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Study design, data acquisition, and planned analyses. |
Collaborator Contribution | CBSU-based MEG facilities and expertise has greatly enhanced translational medicine of FTD, including new experimental medicine studies. |
Impact | abstracts published; papers submitted and published; new experimental studies begun; |
Start Year | 2009 |
Description | GENFI-1 |
Organisation | University College London |
Department | Institute of Neurology |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A new prevalence cohort of genetically detemined FTD or genetically at-risk relatives |
Collaborator Contribution | Coordination of a multicentre study imaging analysis genetics guardians |
Impact | Pilot data for strategic award; several publications; doi: 10.1016/S1474-4422(14)70324-2; doi: 10.1093/brain/awx103; doi: 10.1002/jmri.25751; doi: 10.1016/j.nicl.2017.04.015; 10.1016/j.neurobiolaging.2017.10.008; |
Start Year | 2011 |
Description | ICICLE-PD study of Parkinsons disease cognition |
Organisation | Newcastle University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Characterise cohorts with parkinsonisms in Cambridgeshire. Identify and phenotype patients who develop PD dementia. |
Collaborator Contribution | Characterise cohorts with parkinsonisms in Cambridgeshire. Identify and phenotype patients who develop PD dementia. |
Impact | several publications; doi: 10.1212/WNL.0000000000000066; doi: 10.1093/brain/awu201; doi: 10.1093/brain/awv211; doi: 10.1002/mds.26563; doi: 10.1016/j.parkreldis.2016.04.009; doi: 10.1002/gps.4623; doi: 10.1016/j.parkreldis.2017.01.001; doi: 10.1136/jnnp-2016-315099; |
Start Year | 2010 |
Description | JPND EUFIND - European Ultrahigh Field Imaging Biomarkers for Dementia |
Organisation | EU Joint Programme - Neurodegenerative Disease Research (JPND) |
Country | European Union (EU) |
Sector | Public |
PI Contribution | An international consortium for harmonisation and standardisation of UHF-MRI for Dementia Research. We have contributed expertise, data, and engaged in a pilot study for feasibility and methods development |
Collaborator Contribution | An international consortium for harmonisation and standardisation of UHF-MRI for Dementia Research. Our partners from 20 EU sites have contributed expertise, data, and engaged in a pilot study for feasibility and methods development |
Impact | A project initiation report is submitted to JPND |
Start Year | 2016 |
Description | Mechanisms of inhibition |
Organisation | University of Cambridge |
Department | Department of Psychology |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Framing clinical and non-clinical research questions about the dissociable mechanisms of inhibition in health and diease. Setting behavioural, pharmacological and imaging methods to answer these. |
Collaborator Contribution | Expertise in design and interpretation of experimental studies, and joint supervision of students |
Impact | several articles published; more to come; doi: 10.1093/cercor/bhs070; doi: 10.1016/j.neuroimage.2012.06.058; doi: 10.1038/npp.2012.264; doi: 10.1016/j.neuroimage.2013.10.012; doi: 10.1093/brain/awu032; doi: 10.1016/j.biopsych.2014.01.024; doi: 10.1093/brain/awu117; doi: 10.1523/JNEUROSCI.3093-13.2015; doi: 10.1093/brain/awv133; doi: 10.1093/brain/awv331; doi: 10.1002/hbm.23087; doi: 10.1038/npp.2016.18; doi: 10.1093/brain/aww138; doi: 10.1093/brain/awx101; |
Start Year | 2010 |
Description | Misplaced in space |
Organisation | University of East Anglia |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Development of PE concept, and data sharing. |
Collaborator Contribution | Artistic development of a Dementia outreach exhibition |
Impact | Exhibition in 2017 at the University of East Anglia |
Start Year | 2016 |
Description | NIHR BRC |
Organisation | National Institute for Health Research |
Department | NIHR Cambridge Biomedical Research Centre |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Biomarker development, including cognitive and imaging based deep phenotyping; |
Collaborator Contribution | Cellular, physiological, radio-chemistry, genetic and pharmaceutical innovations within a pipeline for novel drug discovery; |
Impact | several publications; more to come; 10.1017/S1041610216002143; 10.1016/j.arr.2017.03.002; 10.1016/j.neurobiolaging.2017.03.012; 10.1093/brain/awx101; 10.1016/j.nicl.2017.04.015; 10.3233/JAD-170129; 10.1016/j.neuropsychologia.2017.08.022; 10.1093/ijnp/pyx040; 10.1136/jnnp-2017-316402; 10.1007/s00415-017-8647-0; 10.3233/JAD-170344; 10.1016/j.neurobiol aging.2017.10.008; 10.1093/brain/awx347; 10.1136/jnnp-2016-314411; 10.1136/bmjopen-2016-013187; 10.1093/brain/aww340; |
Start Year | 2012 |
Description | NIHR BRC |
Organisation | National Institute for Health Research |
Department | NIHR Cambridge Biomedical Research Centre |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Biomarker development, including cognitive and imaging based deep phenotyping; |
Collaborator Contribution | Cellular, physiological, radio-chemistry, genetic and pharmaceutical innovations within a pipeline for novel drug discovery; |
Impact | Adams, N. E., Hughes, L. E., Phillips, H. N., Shaw, A. D., Murley, A. G., Nesbit, D., Cope, T. E., Bevan-Jones, W. R., Passamonti, L., Rowe, J. B. (2020). GABA-ergic dynamics in human frontotemporal networks confirmed by pharmaco magnetoencephalography, Journal of Neuroscience, https://doi.org/10.1523/JNEUROSCI.1689-19.2019. Lewis-Smith, D. J., Wolpe, N., Ghosh, B. C. P., Rowe, J. B. (2020). Alien limb in the corticobasal syndrome: phenomenological characteristics and relationship to apraxia, Journal of Neurology, https://doi.org/10.1007/s00415-019-09672-8. Jabbari, E., Chelban, V., Holland, N., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, j. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J., Zetterberg, H., Russell, L. L., Bocchetta, M., Rohrer, J. D., Williams, N. M., Grosset, D. G., Burn, D. J., Pavese, N., Gerhard, A., Kobylecki, C., Leigh, P. G., Church, A., Hu, M. T. M., Woodside, J., Houlden, H., Rowe, J. B., Morris, H. R. (2020). Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome, JAMA Neurology, doi:10.1001/jamaneurol.2019.4347. van der Ende, E. L,, Meeter, L. H., Poos, J. M., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Papma, J. M., de Jong, F. J., Verberk, I., Teunissen, C. E., Rizopoulos, D., Heller, C., Convery, R. S., Moore, K. M., Bocchetta, M., Neason, M., Cash, D. M., Borroni, B., Galimberti, D., Sanchez-Valle, R., Laforce, Jr R., Moreno, F., Synofzik, M., Graff, C., Masellis, M., Tartaglia, M. C., Rowe, J. B., Vandenberghe, R., Finger, E., Tagliavini, F., de Mendonça, A., Santana, I., Butler, C., Ducharme, S., Gerhard, A., Danek, A., Levin, J., Otto, M., Frisoni, G. B., Cappa, S., Pijnenburg, Y. A. L., on behalf of the GENetic Frontotemporal Dementia Initiative (GENFI), Rohrer, J. D., van Swieten, J. C. (2019). Longitudinal serum neurofilament light chain in genetic frontotemporal dementia: a multicentre cohort study. Lancet Neurology, 18: 1103-1111, https://doi.org/10.1016/S1474-4422(19)30354-0. Shafto, M. A., Henson, R. N., Matthews, F. E., Taylor, J. R., Emery, T., Erzinclioglu, S., Hanley, C., Rowe, J. B., Cusack, R., Calder, A. J., Marslen-Wilson, W. D., Duncan, J., Dalgleish, T., Brayne, C., Cam-CAN, Tyler, L. K. (2019). Cognitive Diversity in a Healthy Aging Cohort: Cross-Domain Cognition in the Cam-CAN Project, Journal of Aging and Health, doi: 10.1177/0898264319878095 [ahead of print], PMID: 31592706 Lansdall, C. J., Coyle-Gilchrist, I. T. S., Vázquez Rodríguez, P., Wilcox, A., Wehmann, E., Robbins, T. W., Rowe, J. B. (2019). Prognostic importance of apathy in syndromes associated with Frontotemporal lobar Degeneration, Neurology, 92(14):e1547-e1557. doi: 10.1212/WNL.0000000000007249, PMID: 30842292, PMC: 6448451. Borchert, B. J., Rittman, T., Rae, C. L., Passamonti, L., Jones, P. S., Vatansever, D., Vazquez-Rodriguez, P., Ye, Z., Nombela, C., Hughes, L. E., Robbins, T. W., Rowe, J. B. (2019). Atomoxetine and citalopram alter brain network organization in Parkinson's disease, Brain Communications, 1:1 fcz013, https://doi.org/10.1093/braincomms/fcz013. PMID: [pending], PMC: [pending]. Nicastro, N., Surendranathan, A., Mak, E., Rowe, J. B.*, O'Brien, J. T.* (2019). 11C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia, Annals of Clinical and Translational Neurology, doi: 10.1002/acn3.50877, PMID: 31507085, PMC: [pending]. Low, A., Mak, E., Malpetti, M., Chouliaras, L., Nicastro, N., Su, L., Holland, N., Rittman, T., Vázquez Rodríguez, P., Passamonti, L., Bevan-Jones, W. R., Jones, P. S., Rowe, J. B.*, O'Brien, J. T.* (2019). Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features, Alzheimer's & Dementia: Diagnosis, Assessment, & Disease Monitoring, 11: 690-699, DOI: https://doi.org/10.1016/j.dadm.2019.08.001, PMID: 31667328, PMC: 6811895. Tavares, T. P., Mitchell, D. G. V., Coleman, K., Shoesmith, C., Bartha, R., Cash, D. M., Moore, K. M., van Swieten, J. C., Borroni, B., Galimberti, D., Tartaglia, M. C., Rowe, J. B., Graff, C., Tagliavini, F., Frisoni, G., Cappa, S., Laforce, R. Jr, de Mendonça, A., Sorbi, S., Wallstrom, G., Masellis, M., Rohrer, J. D., Finger, E. C., GENetic Frontotemporal Dementia Initiative (GENFI) (2019). Ventricular volume expansion in presymptomatic genetic frontotemporal dementia, Neurology, doi: 10.1212/WNL.0000000000008386, PMID: 31578297, PMC: [pending]. Passamonti, L., Tsvetanov, K. A., Jones, P. S., Bevan-Jones, W. R., Arnold, R., Borchert, R. J., Mak, E., Su, L., O'Brien, J. T.*, Rowe, J. B.* (2019). Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance, Journal of Neuroscience, doi: 10.1523/JNEUROSCI.2574-18.2019. PMID: 31320450, PMC: 6733539. Jabbari, E., Woodside, J., Guo, T., Magdalinou, N. K., Chelban, V., Athauda, D., Lees, A. J., Foltynie, T., Houlden, H., Church, A., Hu, M. T., Rowe, J. B., Zetterberg, H., Morris, H. R. (2019). Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes, Journal of Neurology, Neurosurgery and Psychiatry, 90(7):768-773. doi: 10.1136/jnnp-2018-320151. PMID: 30867224, PMC: 6585258. Hughes, L. E., Henson, R. N., Pereda, E., Bruña, R., López-Sanz, D., Quinn, A. J., Woolrich, M. W., Nobre, A. C., Rowe, J. B., Maestú, F., BioFIND Working Group (2019). Biomagnetic biomarkers for dementia: A pilot multicentre study with a recommended methodological framework for magnetoencephalography, Alzheimers & Dementia (Amsterdam, Netherlands), 11:450-462. doi: 10.1016/j.dadm.2019.04.009. PMID: 31431918, PMC: 6579903. Shaw, A. D., Hughes, L. E., Moran, R., Coyle-Gilchrist, I., Rittman, T., Rowe, J. B. (2019). In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies. Cerebral Cortex. 2019. doi: 10.1093/cercor/bhz024. PMID: 31216360. van Eimeren, T., Antonini, A., Berg, D., Bohnen, N., Ceravolo, R., Drzezga, A., Höglinger, G. U., Higuchi, M., Lehericy, S., Lewis, S., Monchi, O., Nestor, P., Ondrus, M., Pavese, N., Peralta, M.C., Piccini, P., Pineda-Pardo, J. Á., Rektorová, I., Rodríguez-Oroz, M., Rominger, A., Seppi, K., Stoessl, A. J., Tessitore, A., Thobois, S., Kaasinen, V., Wenning, G., Siebner, H. R., Strafella, A. P., Rowe, J. B. (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimers & Dementia (Amsterdam, Netherlands). 11:301-309. doi: 10.1016/j.dadm.2019.01.011. PMID: 30984816, PMC: 6446052. Rittman, T., Borchert, R., Jones, P. S., van Swieten, J., Borroni, B., Galimberti, D., Masellis, M., Tartaglia, M. C., Graff, C., Tagliavini, F., Frisoni, G. B., Laforce, R. Jr, Finger, E., Mendonça, A., Sorbi, S., Rohrer, J. D., Rowe, J. B., GENetic Frontotemporal Dementia Initiative (GENFI) (2019). Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia, Neurobioly of Aging, 77:169-177. doi: 10.1016/j.neurobiolaging.2018.12.009, PMID: 30831384; PMC: 6491498. Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T., Arnold, R., Coles, J. P., Aigbirhio, F. I., O'Brien, J. T., Rowe, J. B. (2019). In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier. Annals of Clinical Translational Neurology, 6(2):373-378. doi: 10.1002/acn3.683. PMID: 30847369; PMC: 6389753. |
Start Year | 2017 |
Description | PSP network |
Organisation | Cardiff University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A new netwrok to coordinate clinical and genetic and imaging research of this severe neurodegenerative disorder |
Collaborator Contribution | 1. coordinated recruitment 2. biomarker development |
Impact | PPI acivities; Papers pending; |
Start Year | 2015 |
Description | PSP network |
Organisation | Progressive Supranuclear Palsy Association (PSPA) |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | A new netwrok to coordinate clinical and genetic and imaging research of this severe neurodegenerative disorder |
Collaborator Contribution | 1. coordinated recruitment 2. biomarker development |
Impact | PPI acivities; Papers pending; |
Start Year | 2015 |
Description | PSP network |
Organisation | University College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A new netwrok to coordinate clinical and genetic and imaging research of this severe neurodegenerative disorder |
Collaborator Contribution | 1. coordinated recruitment 2. biomarker development |
Impact | PPI acivities; Papers pending; |
Start Year | 2015 |
Description | PSP network |
Organisation | University of Manchester |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A new netwrok to coordinate clinical and genetic and imaging research of this severe neurodegenerative disorder |
Collaborator Contribution | 1. coordinated recruitment 2. biomarker development |
Impact | PPI acivities; Papers pending; |
Start Year | 2015 |
Description | PSP network |
Organisation | University of Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A new netwrok to coordinate clinical and genetic and imaging research of this severe neurodegenerative disorder |
Collaborator Contribution | 1. coordinated recruitment 2. biomarker development |
Impact | PPI acivities; Papers pending; |
Start Year | 2015 |
Description | Siemens collaboration |
Organisation | Siemens Healthcare |
Country | Germany |
Sector | Private |
PI Contribution | In establishing the new 7T MRI Research Facility, we have actively enganged with Siemens to revise and optimise the facility on an accelarated timescale. We will be the first non-Germany site to test their new Terra System, and to apply Terra to dementia and neuroscience disciplines. |
Collaborator Contribution | ?810,000 budgetary revision and 'no-cost' like-for-like upgrade of core technologies of circa ?750,000. Fellowship, on-site engineer for 12months and Scientist for 18 months circa ?260,000. So, total Siemens contribution ~?1,820,000. Subsequent substantial in kind contribution negotiated |
Impact | Delivery on time and on budget of new facility in 2016. Since 2017: Standard sequences are in in place with good QC/QA, and the scanner is in use for several research studies in clinical populations, ageing and development. The scanner is booked >80% now for clinical and cognitive neuroscience studies. We have negotiated research agreements with Siemens for 4 areas of collaborative development in MRI physics at 7T with the 7T physics group. These include developments in parallel transmit methods in the brain and body; developments in MR spectroscopy; and developments in whole-body metabolic imaging at 7T. |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | Alzheimer's Research UK |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | AstraZeneca |
Department | MedImmune |
Country | United Kingdom |
Sector | Private |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | Cardiff University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | Eli Lilly & Company Ltd |
Country | United Kingdom |
Sector | Private |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | Imperial College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | Janssen Biotech, Inc. |
Country | United States |
Sector | Private |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | King's College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | MRC Dementias Platform UK |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | University College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | University of Exeter |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | University of Glasgow |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Synaptic Health |
Organisation | University of Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Academic leadership and skills in new Dementia research platform; planning and applying for new funding; several meeting and phone conferences; about to initiate NTAD in Cambridge; planning of NTAD study; |
Collaborator Contribution | Expertise in translational neuroscience; planning; meetings; application for further funding; |
Impact | New Therapeutics in Dementia consortium; an interdisciplinary research group of clinicians, cognitive scientists, informatics, pharmaceutical and drug development experts; phase 0 studies for "New Therapeutics in Alzheimer's Disease" and "Deep and Frequent Phenotyping" that are designed to optimise phase II studies of disease modifying therapies and additional opportunities for insights into disease pathogenesis; data collection, analyses and publications still pending; |
Start Year | 2015 |
Description | Tau biology in vivo |
Organisation | AstraZeneca |
Country | United Kingdom |
Sector | Private |
PI Contribution | establishing a new biomedical research platform |
Collaborator Contribution | funding and provision of research materials |
Impact | pending |
Start Year | 2014 |
Description | UK 7T MRI network |
Organisation | Cardiff University |
Department | Brain Research Imaging Centre (CUBRIC) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | establishing a new 7T imaging network, with new CRI funding and MRC Parntership grant. Updated input for 2019 - 2020 - Dr Rodgers (Cambridge Head of 7T MRI Physics) was elected coordinator of the UK7T network from 1 Nov 2019 onwards. |
Collaborator Contribution | establishing a new 7T imaging network, with new CRI funding |
Impact | A series of workshops and symposia, for training, education and research exchange. Topics include 7T-Safety, fMRI, Parallel Transmit and research updates. The project is multi-disciplinary, between clinicians in neurology, psychiatry, radiology and physicists, engineers, and data informaticians. |
Start Year | 2016 |
Description | UK 7T MRI network |
Organisation | University of Glasgow |
Department | Institute of Neuroscience and Psychology |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | establishing a new 7T imaging network, with new CRI funding and MRC Parntership grant. Updated input for 2019 - 2020 - Dr Rodgers (Cambridge Head of 7T MRI Physics) was elected coordinator of the UK7T network from 1 Nov 2019 onwards. |
Collaborator Contribution | establishing a new 7T imaging network, with new CRI funding |
Impact | A series of workshops and symposia, for training, education and research exchange. Topics include 7T-Safety, fMRI, Parallel Transmit and research updates. The project is multi-disciplinary, between clinicians in neurology, psychiatry, radiology and physicists, engineers, and data informaticians. |
Start Year | 2016 |
Description | UK 7T MRI network |
Organisation | University of Nottingham |
Department | School of Biomedical Sciences Nottingham |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | establishing a new 7T imaging network, with new CRI funding and MRC Parntership grant. Updated input for 2019 - 2020 - Dr Rodgers (Cambridge Head of 7T MRI Physics) was elected coordinator of the UK7T network from 1 Nov 2019 onwards. |
Collaborator Contribution | establishing a new 7T imaging network, with new CRI funding |
Impact | A series of workshops and symposia, for training, education and research exchange. Topics include 7T-Safety, fMRI, Parallel Transmit and research updates. The project is multi-disciplinary, between clinicians in neurology, psychiatry, radiology and physicists, engineers, and data informaticians. |
Start Year | 2016 |
Description | UK 7T MRI network |
Organisation | University of Oxford |
Department | Oxford Centre for Functional MRI of the Brain (FMRIB) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | establishing a new 7T imaging network, with new CRI funding and MRC Parntership grant. Updated input for 2019 - 2020 - Dr Rodgers (Cambridge Head of 7T MRI Physics) was elected coordinator of the UK7T network from 1 Nov 2019 onwards. |
Collaborator Contribution | establishing a new 7T imaging network, with new CRI funding |
Impact | A series of workshops and symposia, for training, education and research exchange. Topics include 7T-Safety, fMRI, Parallel Transmit and research updates. The project is multi-disciplinary, between clinicians in neurology, psychiatry, radiology and physicists, engineers, and data informaticians. |
Start Year | 2016 |
Title | Atomoxetine in PD |
Description | new drug strategy for impulsivity in PD tested for first time in two complementary studies |
Type | Therapeutic Intervention - Drug |
Current Stage Of Development | Early clinical assessment |
Year Development Stage Completed | 2013 |
Development Status | Closed |
Impact | reduced impulsivity in selected patients |
Title | Citalopram |
Description | SSRI assessment for FTD impulsivity and netwrok reorganisation |
Type | Therapeutic Intervention - Drug |
Current Stage Of Development | Early clinical assessment |
Year Development Stage Completed | 2013 |
Development Status | Under active development/distribution |
Impact | New experimental medicine trials planned |
Title | Tiagabine in FTLD |
Description | New drug strategy for impulsivity in FTLD tested for first time. |
Type | Therapeutic Intervention - Drug |
Current Stage Of Development | Early clinical assessment |
Year Development Stage Completed | 2021 |
Development Status | Under active development/distribution |
Clinical Trial? | Yes |
Impact | Reduced impulsivity in selected patients. |
Title | iElectrodes toolbox |
Description | iElectrodes is an opensource Matlab toolbox for intracranial electrode (SEEG and ECoG) localization and labeling. |
Type Of Technology | Webtool/Application |
Year Produced | 2016 |
Impact | None to date |
URL | https://sourceforge.net/p/ielectrodes/wiki/Home/ |
Description | "The Motor Side of the FTD Spectrum" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Delivered talk to a mixed audience on the motor side of the FTD spectrum. |
Year(s) Of Engagement Activity | 2021 |
URL | https://wfneurology.org/public/downloads/p9XPX/WCN-2021-Timetable-at-a-glance-Virtual-Congress-26.8.... |
Description | 23rd National Dementia Conference: Talk on "Frontotemporal Dementia" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | An update on FTD landscape and research output from Rowe group. |
Year(s) Of Engagement Activity | 2021 |
Description | ARUK Clinical Conference. talk titled "What's new in Frontotemporal Dementia?" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | This conference focussed on the themes of research, innovation, and implementing change in clinical practice. |
Year(s) Of Engagement Activity | 2021 |
Description | Advisor on tv drama on the theme of dementia |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | TV Soap script editorial advisor on dementia theme |
Year(s) Of Engagement Activity | 2021,2022 |
Description | BBC Newsnight documentary |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Cogntiive enhancement and psychology testing demonstrated and discussed as part of feature within Newsnight program Greater awareness in the public of both the medical and ethical issues of cognitive enhancement, and also the process of research |
Year(s) Of Engagement Activity | 2011 |
Description | BBC Science Club |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Discussion of memory inhibition, with Dr Anderson and presented Jessica Hynes, BBC2 pending |
Year(s) Of Engagement Activity | 2012 |
Description | Brain Conference, talk given on "Apathy and Impulsivity" |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Oral presentation during cognition and dementia theme of Brain conference 2021. |
Year(s) Of Engagement Activity | 2021 |
Description | Brain and Mind Open day |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | Yes |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Open lectures in CBU science, including work on music and PD, led by Dr Grahn and Dr Hughes, Mr Wolpe and other group members "the dementia challenge" 2013 Highly popular annual event |
Year(s) Of Engagement Activity | 2007,2009,2013,2015 |
Description | Cambridge Imaging Festival - Talk: New directions in dementia imaging |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | This is a meeting of users and experts within the Cambridge NHS and academic community. Results and data are shared as well as new perspectives and applications for novel imaging methods. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.mrc-cbu.cam.ac.uk/wp-content/uploads/2021/05/Programme-Cambridge-Imaging-Festival-2021.p... |
Description | Conversion dystonia |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | New research results into 'hysterical' or conversion disorders, using brain imaging High media interest in the UK and abroad. |
Year(s) Of Engagement Activity | 2013 |
Description | Cope/Rowe - Alzheimer's breakthrough? Scientists show how toxic protein rips through the brain (2018). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Article on Cope et al., Brain. By Giles Sheldrick. Express - online. www.express.co.uk/life-style/health/900212/Alzheimer-s-disease-toxic-protein-rips-through-brain-scientists-reveal |
Year(s) Of Engagement Activity | 2018 |
URL | http://www.express.co.uk/life-style/health/900212/Alzheimer-s-disease-toxic-protein-rips-through-bra... |
Description | Cope/Rowe - Alzheimer's protein may spread like an infection, human brain scans suggest (2018). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Article on Cope et al., 2018 in Brain. By Meredith Wadman. Science Magazine www.sciencemag.org http://www.sciencemag.org/news/2018/01/alzheimer-s-protein-may-spread-infection-human-brain-scans-suggest |
Year(s) Of Engagement Activity | 2018 |
URL | http://www.sciencemag.org/news/2018/01/alzheimer-s-protein-may-spread-infection-human-brain-scans-su... |
Description | Cope/Rowe - How Alzheimer's disease spreads throughout the brain - new study. The Conversation (2018). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Media article on Cope et al., Brain in "The Conversation". |
Year(s) Of Engagement Activity | 2018 |
URL | http://theconversation.com/how-alzheimers-disease-spreads-throughout-the-brain-new-study-89692 |
Description | Cope/Rowe - Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread may prevent the disease from taking hold (2018). |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Press release by the Cambridge University regarding new article published by Cope et al., in Brain. |
Year(s) Of Engagement Activity | 2018 |
Description | Dr M Malpetti - Host of Clinical Neurosciences Seminar & Conversation with Prof. JB Rowe |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Discussion on "From mechanisms to treatment, in disorders of frontotemporal lobar degeneration." |
Year(s) Of Engagement Activity | 2021 |
Description | Dr Maura Malpetti - ROWE GROUP MEMBER Invited speaker at Alzheimer's Association International Conference |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Invited as a speaker on Brain inflammation in frontotemporal dementia. ISTAART conversation with patients and carers. |
Year(s) Of Engagement Activity | 2021 |
Description | Dr Maura Malpetti - ROWE GROUP MEMBER Invited speaker at Alzheimer's RESEARCH UK |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | TALK TITLE: Brain imaging in dementia: for better understanding and treatment of human disease |
Year(s) Of Engagement Activity | 2021 |
Description | Dr Maura Malpetti - ROWE GROUP MEMBER Organizing committee member "My memory clinic and me" Cambridge Festival 2021 |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | My memory clinic and me" at Cambridge Festival 2021 - a session held for those interested in neurodegenerative diseases. |
Year(s) Of Engagement Activity | 2021 |
URL | https://ftd.neurology.cam.ac.uk/events/201cme-and-my-memory-clinic201d |
Description | FTD carers group |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Type Of Presentation | Workshop Facilitator |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | 45 people, moslty fmailies, some allied professionals, regarding current research and activity, and practical management of symptoms new audit of care new direct input from DWP to clinic education |
Year(s) Of Engagement Activity | 2011,2012,2013,2014,2015,2016 |
Description | Frontotemporal Dementia Support Group National Annual Seminar |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Gave a talk titled "Frontotemporal Dementia: introduction and pathways to progress" with the Rare Dementia Support Group. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.youtube.com/watch?v=xP_yFWzb40g |
Description | Hughes - CBU Open Science Workshop 2016, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK (2016) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Hughes, L. (22nd November 2016). CBU Open Science Workshop 2016, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK. |
Year(s) Of Engagement Activity | 2016 |
Description | Inernational symposium on PSP/CBD |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | International symposium, including talk and posters from our group, on progress in PSP and CBD reesarch Engagement with Pharma |
Year(s) Of Engagement Activity | 2018 |
Description | International Society FTD Conference - "Magnetoencephalography (MEG) and frontotemporal dementia' |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | The International Conference on Frontotemporal Dementias (ICFTD) is l recognized as the primary venue for the synthesis, exchange, and dissemination of research evidence related to FTD, where experts from diverse backgrounds share recent discoveries, insights, and opinions. The talk presented hilighted our groups experiences with applying MEG methods to FTD patients in early research trials. |
Year(s) Of Engagement Activity | 2021 |
Description | Invited session chair at Alzheimer's Association International Conference 2021, USA - Dr M Malpetti |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Chaired session on "Neuroimaging: Molecular Imaging of Novel Biomarkers for Neurodegeneration and ADRD" session at AAIC 2021 (07/2021 - Denver USA) |
Year(s) Of Engagement Activity | 2021 |
Description | Invited speaker at 7TMRI group University of Cambridge- Dr Amirhossein Jafarian |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Title: Prior in DCM and MRS informed dynamic causal modelling. |
Year(s) Of Engagement Activity | 2021 |
Description | MEGUK Oral Presentation by Dr Amirhossein Jafarian (Rowe Group) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Gave an oral presentation titled Multimodal Dynamic causal modelling |
Year(s) Of Engagement Activity | 2021 |
Description | MRC CBU Science Night - Cambridge Science Festival 2019 |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Demonstrations of research studies, including VR game |
Year(s) Of Engagement Activity | 2019 |
URL | http://www.mrc-cbu.cam.ac.uk/blog/2019/01/mrc-cbu-science-night-cambridge-science-festival-2019/ |
Description | Mind over Chatter Podcast: Dementia |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | What causes dementia? And how do we diagnose and treat it? Is there anything we can do to stop ourselves from developing dementia? These are the crucial questions we'll be exploring with clinical neuropsychologist Barbara Sahakian, sociologist Richard Milne, and neurologist James Rowe. In this episode, we'll find out more about what dementia actually is, some surprising factors that increase a person's risk of developing dementia, and computer games that can actually help detect and diagnose dementia. |
Year(s) Of Engagement Activity | 2022 |
URL | https://podcasts.apple.com/gb/podcast/dementia-risks-diagnosis-and-prevention/id1542332564?i=1000549... |
Description | My Memory Clinic and Me |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Presented at an event titled My Memory Clinic and Me as part of the Cambridge Festival in March 2021. The Cambridge Memory Clinic provides assessment and management for a wide range of memory and cognitive disorders, for example, due to neurodegeneration (Alzheimer's disease, Mild Cognitive Impairment, Frontotemporal dementia, Dementia with Lewy Bodies) and more. A discussion was help about memory clinics in the context of dementia. How they can help, and what to expect - including their role in leading research that matters to patient care. Short presentations followed by a live Q&A session with consultant neurologists. |
Year(s) Of Engagement Activity | 2021 |
URL | https://ftd.neurology.cam.ac.uk/events/201cme-and-my-memory-clinic201d |
Description | National Advertising Campaign with Alzheimer's Research UK |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | National advertising campaign |
Year(s) Of Engagement Activity | 2021,2022 |
Description | Nesbit - Talk presented at the meeting on "Your ageing brain. Use it or loose it". Meeting by Sevenoaks and Knole U3A Science Groups (2016) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Nesbit, D. (7th June, 2016). Talk presented at the meeting on "Your ageing brain. Use it or loose it". Meeting by Sevenoaks and Knole U3A Science Groups |
Year(s) Of Engagement Activity | 2016 |
Description | Nesbitt - Q A with Dr David Nesbitt. The London Brain Project. Special Edition on Beyond Memories (2017) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Nesbitt, D. (28th September 2017). Q&A with Dr David Nesbitt. The London Brain Project. Special Edition on "Beyond Memories". |
Year(s) Of Engagement Activity | 2017 |
Description | News article on cognition research |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.news-medical.net/news/20220110/Poor-cognition-may-be-part-of-normality-in-older-age-rese... |
Description | News article on cognition research |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.healthline.com/health-news/dementia-can-be-detected-early |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.medicalnewstoday.com/articles/predicting-alzheimers-risk-why-cognitive-testing-alone-may... |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.thehealthnewsexpress.com/alzheimer_disease_dementia/cognitive-decline-not-always-a-sign-... |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.medica-tradefair.com/en/News/News_from_the_Editors/Cognitive_decline_not_always_a_sign_o... |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://en.brinkwire.com/health/alzheimers-disease-isnt-always-caused-by-cognitive-decline/ |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://scitechdaily.com/cognitive-decline-is-not-always-a-sign-of-alzheimers-disease/ |
Description | News article on how cognitive frailty may be part of normal aging |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | The recent publication titled "Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease" was featured on a health website suggesting that poor cognition may be part of normality in older age. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talker.news/2022/01/11/elderly-people-can-show-signs-of-mental-decline-without-getting-demen... |
Description | OLS/UKRI cross sector specialist workshop/committee for new national dementia initiative strategy for 2022 |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | Meeting with No.10 officials on UK Dementia landscape. |
Year(s) Of Engagement Activity | 2021,2022 |
Description | PD newsletter |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | feedback on research projects on PD to the PD research database panel, and PSP association newsletter increased engagement in research particpation, by pateitns and their healthy contacts |
Year(s) Of Engagement Activity | 2007,2008,2009,2010,2014,2015 |
Description | PD nurses |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | 100 nurse specialsits and allied professionals to learn about dementia and neurodegeneration, including research perspectives. CDC professionals Q&A Clinic based teaching tbc |
Year(s) Of Engagement Activity | 2013,2014,2015,2016 |
Description | PPE - Cambridge university Hospitals Trust members |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | An evening event for the members of the Trust (patients, and local public) to discuss advances in dementia research and care, including the insights from new technologies |
Year(s) Of Engagement Activity | 2019 |
Description | PSPA - health and social care professionals |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | challenges of PSP and its research . |
Year(s) Of Engagement Activity | 2012,2013,2014,2015 |
Description | PSPA guidelines |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | Yes |
Type Of Presentation | Workshop Facilitator |
Geographic Reach | National |
Primary Audience | Health professionals |
Results and Impact | A working party to develop new national guidelines Published guidelines |
Year(s) Of Engagement Activity | 2012 |
Description | Rowe - 11th Cambridge Dementia Course. Oliver Cousins for Advances in Clinical Neuroscience and Rehabilitation (ACNR), (2017). |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (11th April 2017). 11th Cambridge Dementia Course. Oliver Cousins for Advances in Clinical Neuroscience and Rehabilitation (ACNR). |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.acnr.co.uk/2017/04/11th-cambridge-dementia-course/ |
Description | Rowe - BBC Look East (2016) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | 7T for dementia research |
Year(s) Of Engagement Activity | 2016 |
Description | Rowe - Brain training app found to improve memory in people with mild cognitive impairment. University of Cambridge for Science Daily (2017) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (3rd July 2017). 'Brain training' app found to improve memory in people with mild cognitive impairment. University of Cambridge for Science Daily. www.sciencedaily.com/releases/2017/07/170703083310.htm |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.sciencedaily.com/releases/2017/07/170703083310.htm |
Description | Rowe - Cambridge Neuroscientists involved in large multi-centre Alzheimer's study. Cambridge Neuroscience News, UK (2016) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (22th August 2016). Cambridge Neuroscientists involved in large multi-centre Alzheimer's study. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=886b81aa3d |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=886b81aa3d |
Description | Rowe - Cambridge Science Festival (2017) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Lecture at Cambridge Science Festival |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - Cambridge extends world leading role for medical imaging with powerful new brain and body scanners. Cambridge Neuroscience News, UK (2016). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | • Rowe, J. B. (25th October 2016). Cambridge extends world leading role for medical imaging with powerful new brain and body scanners. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=fe046fcc97 |
Year(s) Of Engagement Activity | 2016 |
Description | Rowe - Cambridge extends world leading role for medical imaging with powerful new brain and body scanners. University of Cambridge News for Medical Design Technology (2016) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (24th October 2016). Cambridge extends world leading role for medical imaging with powerful new brain and body scanners. University of Cambridge News for Medical Design Technology. http://www.cam.ac.uk/research/news/cambridge-extends-world-leading-role-for-medical-imaging-with-powerful-new-brain-and-body-scanners |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.cam.ac.uk/research/news/cambridge-extends-world-leading-role-for-medical-imaging-with-pow... |
Description | Rowe - Existing drugs step up in battle against neurodegenerative disease. Magazine of the PSP Association (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (9th October 2017). Existing drugs step up in battle against neurodegenerative disease. Magazine of the PSP Association. |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - FTD Carers' Meeting, Department of Clinical Neurosciences, University of Cambridge, UK (2014) |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (24th March 2014). FTD Carers' Meeting, Department of Clinical Neurosciences, University of Cambridge, UK. |
Year(s) Of Engagement Activity | 2014 |
Description | Rowe - FTD Carers' Meeting, Department of Clinical Neurosciences, University of Cambridge, UK (2015). |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (30th March 2015). FTD Carers' Meeting, Department of Clinical Neurosciences, University of Cambridge, UK. |
Year(s) Of Engagement Activity | 2015 |
Description | Rowe - FTD Carers' Meeting. Department of Clinical Neurosciences, University of Cambridge (2017). |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (13th September 2017). FTD Carers' Meeting. Department of Clinical Neurosciences, University of Cambridge; give feedback to carers and also get feedback from them. |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - FTD Carers' Meeting. Department of Clinical Neurosciences, University of Cambridge (PPE) (2016). |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (8th February 2016). FTD Carers' Meeting. Department of Clinical Neurosciences, University of Cambridge (PPE). |
Year(s) Of Engagement Activity | 2016 |
Description | Rowe - FTD-UK Annual Meeting (2017) - Debate |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | A discussion of imaging's contribution to FTD diagnosis, prognosis and stratification |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - First dementia patient is scanned. BRC Communications, R D Newsletter, Cambridge Biomedical Research Centre (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (6th October 2017). First dementia patient is scanned. BRC Communications, R&D Newsletter, Cambridge Biomedical Research Centre. |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - For the Dementia Awareness Week: Professor James Rowe of @CamNeuro on Cambridge s role in dementia research. University of Cambridge, (2017). |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (17th May 2017). For the Dementia Awareness Week: Professor James Rowe of @CamNeuro on #Cambridge's role in dementia research. University of Cambridge, Cambridge TV @cambridgetvnews (Twitter Video). https://twitter.com/cambridgetvnews/status/864790164861800448; awareness for dementia |
Year(s) Of Engagement Activity | 2017 |
URL | http://twitter.com/cambridgetvnews/status/864790164861800448 |
Description | Rowe - He couldn t believe there was no cure: Husband of ski instructor, 32, struck down by rare dementia shortly after their wedding has shed so many tears since her diagnosis, her father reveals. Andrew Young for Daily Mail Online (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (4th September 2017). He couldn't believe there was no cure': Husband of ski instructor, 32, struck down by rare dementia shortly after their wedding has shed 'so many tears' since her diagnosis, her father reveals. Andrew Young for Daily Mail Online. http://www.dailymail.co.uk/news/article-4851272/Husband-couldn-t-believe-no-cure.html; mentions only James Rowe |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.dailymail.co.uk/news/article-4851272/Husband-couldn-t-believe-no-cure.html |
Description | Rowe - Her tester programleder Emma < |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (14th May 2016). Her tester programleder Emma <>. Kristin Granbo for NRK News. |
Year(s) Of Engagement Activity | 2016 |
URL | https://www.nrk.no/dokumentar/xl/her-tester-programleder-emma-_smart-drug_-1.12916450 |
Description | Rowe - How a blood test could save you from infertility: Women could be spared surgery which risks their ability to have children. Carol Davis for Daily Mail Online (2016) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (19th November 2016). How a blood test could save you from infertility: Women could be spared surgery which risks their ability to have children. Carol Davis for Daily Mail Online. http://www.dailymail.co.uk/health/article-3952546/How-blood-test-save-infertility-Women-spared-surgery-risks-ability-children.html |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.dailymail.co.uk/health/article-3952546/How-blood-test-save-infertility-Women-spared-surge... |
Description | Rowe - James Rowe appointed as Professor in Department of Clinical Neurosciences. Cambridge Neuroscience News, UK (2015) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (22th June 2015). James Rowe appointed as Professor in Department of Clinical Neurosciences. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=4cf805cac3 |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=4cf805cac3 |
Description | Rowe - Look East. The latest news, sport and weather for the East of England. BBC One. (Feature about PSP Association) (2017) |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (16th May 2017). Look East. The latest news, sport and weather for the East of England. BBC One. (Feature about PSP Association). |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - Meeting the Scientist. Cambridge Science Festival, Cambridge, UK (25th March 2018) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Increase public awareness for rare dementia types (PSP, SD, frontotemporal dementia). |
Year(s) Of Engagement Activity | 2018 |
Description | Rowe - Misplace in Space (2016-2017) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (1st-6th September 2017). Misplaced in Space. Emily Fisher, Work by MA students shown in the MA Degree Show 2017 with work related to individual's experience to live with dementia. Norwich University of the Arts, UK. http://www.nua.ac.uk/ma-degree-show-catalogue-2017/emily-fisher/; An interactive exhibition about living with Dementia, |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.nua.ac.uk/ma-degree-show-catalogue-2017/emily-fisher/ |
Description | Rowe - NIHR Westminster: Dementia meeting the challenge (2012) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Type Of Presentation | Poster Presentation |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presenting the case for cognitive phenotyping and imaging endpoints in magement and drug innovation, including new cognitive technologies new NDA with pharma, discussions ongoing |
Year(s) Of Engagement Activity | 2012 |
Description | Rowe - NIMROD study. BRC Communications, R D Newsletter, Cambridge Biomedical Research Centre (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (6th October 2017). NIMROD study. BRC Communications, R&D Newsletter, Cambridge Biomedical Research Centre. |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - Norwegian TV - Modafinil test by programme leader Emma Claire (2017) |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | On cognitive enhancement |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe - Opening the black box. Research Horizons - Pioneering research from the University of Cambridge, Issue 29 (2016). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (29th February 2016). Opening the black box. Research Horizons - Pioneering research from the University of Cambridge, Issue 29. |
Year(s) Of Engagement Activity | 2016 |
Description | Rowe - PCA support group (2015) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | PCA group - discussion of clicnial and reseaerch topics |
Year(s) Of Engagement Activity | 2015,2016 |
Description | Rowe - PSP Matters (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Research update and progress for PSPA |
Year(s) Of Engagement Activity | 2016,2017 |
Description | Rowe - Patients recovering from depression show improvements in memory from the drug modafinil. Cambridge Neuroscience News, UK (2017) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (19th January 2017). Patients recovering from depression show improvements in memory from the drug modafinil. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=d6523fd0d6 |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=d6523fd0d6 |
Description | Rowe - Report on a very successful Imaging the Nervous System Symposium. Cambridge Neuroscience News, UK (2015). |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (8th October 2015). Report on a very successful 'Imaging the Nervous System' Symposium. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=19657b8d6b |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=19657b8d6b |
Description | Rowe - Schizophrenia and the teenage brain: How can imaging help? The University of Cambridge for Medical Design Technology (2016). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (22nd February 2016). Schizophrenia and the teenage brain: How can imaging help? The University of Cambridge for Medical Design Technology. https://www.mdtmag.com/news/2016/02/schizophrenia-and-teenage-brain-how-can-imaging-help |
Year(s) Of Engagement Activity | 2016 |
URL | https://www.mdtmag.com/news/2016/02/schizophrenia-and-teenage-brain-how-can-imaging-help |
Description | Rowe - She used to light up a room - but now 'beautiful' Becky from Suffolk finds it hard to speak after crushing dementia diagnosis. Emily Townsend for East Anglian Daily Times (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (11th September 2017). She used to light up a room - but now 'beautiful' Becky from Suffolk finds it hard to speak after crushing dementia diagnosis. Emily Townsend for East Anglian Daily Times. http://www.eadt.co.uk/news/she-used-to-light-up-a-room-but-now-beautiful-becky-from-suffolk-finds-it-hard-to-speak-after-crushing-dementia-diagnosis-1-5189016; mentions James Rowe |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.eadt.co.uk/news/she-used-to-light-up-a-room-but-now-beautiful-becky-from-suffolk-finds-it... |
Description | Rowe - The new scanners that can really get inside your head. Robin McKie for the Guardian (2016). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (23rd October 2016). The new scanners that can really get inside your head. Robin McKie for the Guardian. https://www.theguardian.com/science/2016/oct/23/powerful-brain-scanners-cambridge-neuroscience |
Year(s) Of Engagement Activity | 2016 |
URL | https://www.theguardian.com/science/2016/oct/23/powerful-brain-scanners-cambridge-neuroscience |
Description | Rowe - Video abstract: Study suggests new treatment for impulsivity in some dementia patients. Cambridge Neuroscience News, UK (2015) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (25th June 2015). Video abstract: Study suggests new treatment for impulsivity in some dementia patients. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=86cc5c6e76 |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=86cc5c6e76 |
Description | Rowe Group Member Dr NEGIN HOLLAND gave talk: Synaptic imaging in dementia and neurodegenerative disease @ Cambridge Imaging Festival |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | This is a meeting of users and experts within the Cambridge NHS and academic community. Results and data are shared as well as new perspectives and applications for novel imaging methods. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.mrc-cbu.cam.ac.uk/wp-content/uploads/2021/05/Programme-Cambridge-Imaging-Festival-2021.p... |
Description | Rowe, 'Brain training' app found to improve memory in people with mild cognitive impairment. Cambridge Neuroscience News, UK (2017) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Rowe, J. B. (18th July 2017). 'Brain training' app found to improve memory in people with mild cognitive impairment. Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=349646f424 |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=349646f424 |
Description | Rowe, J. B. (11th October 2016). As fake 'study pills' become a staple of University life we speak to two students who reveal the horrifying consequences of brain boosting drugs. Matt Quinton for the Sun. |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Rowe, J. B. (11th October 2016). As fake 'study pills' become a staple of University life we speak to two students who reveal the horrifying consequences of brain boosting drugs. Matt Quinton for the Sun. https://www.thesun.co.uk/living/1949817/as-fake-study-pills-become-a-staple-of-university-life-we-speak-to-two-students-who-reveal-the-horrifying-consequences-of-brain-boosting-drugs/ |
Year(s) Of Engagement Activity | 2016 |
URL | https://www.thesun.co.uk/living/1949817/as-fake-study-pills-become-a-staple-of-university-life-we-sp... |
Description | Rowe, J. B. (28th September 2017) Understanding frontotemporal dementia: an interview with Professor James Rowe - Interview for the National Institute for Health Research (NIHR) (2017) |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Rowe, J. B. (28th September 2017) Understanding frontotemporal dementia: an interview with Professor James Rowe. Interview for the National Institute for Health Research (NIHR). https://www.nihr.ac.uk/news-and-events/features/behind-the-research/Understanding-frontotemporal-dementia.htm |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.nihr.ac.uk/news-and-events/features/behind-the-research/Understanding-frontotemporal-deme... |
Description | Rowe/Team - Cambridge Science Festival (2017) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | A lecture on the challenge of dementia as part of the Cambridge Science Festival |
Year(s) Of Engagement Activity | 2017 |
Description | Rowe/Team - MEG and Me (2015) |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | ISSF grant awarded for public engagement with scientific experiment, design, execution and intepretation, filmed by Cambridge TV. (22nd March 2015). IFFS sponsored study of "MEG and ME - Design your own brain experiment" with public meetings to design a MEG experiment, take part in it, and be part of the interpretation of result. Presentation at the Cambridge Science Festival 2015. https://vimeo.com/122974384; https://timrittman.wordpress.com/2014/11/01/meg-and-me-design-your-own-brain-experiment/ |
Year(s) Of Engagement Activity | 2015 |
Description | Rowe/Team - Pint of Science (2015 and 2016) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Several team members in highly popular PoS events within Cambridge Science Festival |
Year(s) Of Engagement Activity | 2015,2016 |
Description | Rowe/Team - The University of the third age (U3A) (2016) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | The CamCAN project including CC-Frail from ACA5, was the focus of a special day event organised by the U3A |
Year(s) Of Engagement Activity | 2016 |
Description | Rowe: FTD carers meeting (2017) |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Research discussion to regional carers |
Year(s) Of Engagement Activity | 2017 |
Description | School visits years 2-4 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | discussion of brains, their funciton and protection, with models and animal brains, and exercises. 70 children, Has become a regular and highly popular activity. Increased awareness of the amazing functions of the brain, and the need to look after it - linked to road safety, exercise and education. |
Year(s) Of Engagement Activity | 2010,2011,2014 |
Description | Session Chair: Cognition at Brain 2022 Conference |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Chaired session on congnition with research presentations on: 1. Transdiagnostic approaches to cognitive disorders and their underlying brain pathology 2. Dissociable brain microstructural diffusivity changes underlying visual short -term memory deficits in Alzheimer's disease. 3. Bayesian Brains and the origin of functional disorders. 4. 'Socioeconomic status impacts cognitive and socioemotional processes in healthy ageing: evidence from Latin American older adults. 5. Noradrenergic treatment of cognitive disorders: big news from the blue spot. |
Year(s) Of Engagement Activity | 2022 |
URL | https://thebrainconference.co.uk/brain-conference-schedule/ |
Description | Seven lab members (22nd March 2018). 5k for the PSP Association to raise money to support people affected by CBD & PSP, Cambridge, UK. |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | Run for PSP and CBD to increase awareness. https://www.pspassociation.org.uk/fundraising/5kforpspa/; promoted on twitter |
Year(s) Of Engagement Activity | 2018 |
Description | Specialist PSP Sub-group @ Movement Disorder Society International Conference: UHF 7T Imaging |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Expert panel meeting on imaging and Progressive supranuclear palsy. |
Year(s) Of Engagement Activity | 2021 |
Description | Talk at - Alzheimer's Association International Conference 2021, Dr Maura Malpetti |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | "Microglial activation and atrophy in frontal cortex predict executive dysfunction in frontotemporal dementia" - Alzheimer's Association International Conference |
Year(s) Of Engagement Activity | 2021 |
Description | Talk by Dr M Malpetti at (ISTAART) Scientific Meeting: What have we learnt from PET in FTD in the last 10 years? |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | "What have we learnt from PET in FTD in the last 10 years" - ISTAART FTD and Neuroimaging PIAs webinar: An update on neuroimaging in frontotemporal dementia (virtual event) |
Year(s) Of Engagement Activity | 2021 |
Description | Talk by Dr M Malpetti at Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Scientific Meeting |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Talk title: Neuroinflammation in medial temporal regions predicts cognitive decline in dementia with Lewy bodies |
Year(s) Of Engagement Activity | 2021 |
Description | Talk by Dr M Malpetti at Clinical Neurosciences Away Day, Cambridge University |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Talk title: Neuroinflammation in frontotemporal lobar degeneration: a target for treatment? |
Year(s) Of Engagement Activity | 2021 |
Description | The Dementia UK Ecosystem and Innovations in biomarkers @ Cambridge Memory Meeting |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | The aim of this Cambridge-wide memory group is to encourage interaction between the many local labs working on the psychology/neuroscience of short- and long-term memory, both human and non-human. The talk given to this audience gave an overview of the key UK institutions and partners involved in dementia research aimed at identifying new biomarkers for plausibale clinical translation. |
Year(s) Of Engagement Activity | 2021 |
URL | http://www.memlab.psychol.cam.ac.uk/CAMM/index.html |
Description | Tim Sandhu Talk @ CamBrain Cambridge Neuroscience Society |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Undergraduate students |
Results and Impact | Oral presentation to junior researchers or those interested in neuroscience. |
Year(s) Of Engagement Activity | 2021 |
Description | Tomassini - Tutor for hands-on sessions for pupils on the use of magnetoencephalography and electroencephalography in neuroscience. Villiers Park Educational Trust, Cambridge, UK (2016) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | Tomassini, A. (2016). Tutor for hands-on sessions for pupils on the use of magnetoencephalography and electroencephalography in neuroscience. Villiers Park Educational Trust, Cambridge, UK. |
Year(s) Of Engagement Activity | 2016 |
Description | Tsvetanov - A well-connected brain is the key to healthy mental ageing. BBSRC news stories and features (2016). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Tsvetanov, K. A. (18th March 2016). A well-connected brain is the key to healthy mental ageing. BBSRC news stories and features. http://www.bbsrc.ac.uk/news/health/2016/160318-pr-well-connected-brain-key-healthy-mental-ageing/ |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.bbsrc.ac.uk/news/health/2016/160318-pr-well-connected-brain-key-healthy-mental-ageing/ |
Description | Tsvetanov - Human brains age less than previously thought Interview with MedicalResearch.com (2015) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Tsvetanov, K. A. (20th March 2015). Human brains age less than previously thought Interview with MedicalResearch.com. https://medicalresearch.com/author-interviews/human-brains-age-less-than-previously-thought/12840/ |
Year(s) Of Engagement Activity | 2015 |
URL | https://medicalresearch.com/author-interviews/human-brains-age-less-than-previously-thought/12840/ |
Description | Tsvetanov - Human brains age less than previously thought. BBSRC news stories and features (2015) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Tsvetanov, K. A. (5th March 2015). Human brains age less than previously thought. BBSRC news stories and features. http://www.bbsrc.ac.uk/news/health/2015/150305-pr-human-brains-age-less-than-thought/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bbsrc+%28BBSRC+-+News+stories+and+features%29 |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.bbsrc.ac.uk/news/health/2015/150305-pr-human-brains-age-less-than-thought/?utm_source=fee... |
Description | Tsvetanov - Human brains age less than previously thought. CamCAN Newsletter (2015) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Tsvetanov, K. A. (2015). Human brains age less than previously thought. CamCAN Newsletter. |
Year(s) Of Engagement Activity | 2015 |
Description | Tsvetanov - Journal cover image of Human Brain Mapping, Issue 6 (2015) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Tsvetanov, K. A. (2015). Journal cover image of Human Brain Mapping, Issue 6. |
Year(s) Of Engagement Activity | 2015 |
Description | Tsvetanov - Talk presented at the meeting on "Your ageing brain. Use it or loose it". Meeting by Sevenoaks and Knole U3A Science Groups (2016) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Tsvetanov, K. (7th June, 2016). Talk presented at the meeting on "Your ageing brain. Use it or loose it". Meeting by Sevenoaks and Knole U3A Science Groups |
Year(s) Of Engagement Activity | 2016 |
Description | Tsvetanov - Your brain might not be as "old" as you think. University of Cambridge Research Features (2015). |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Tsvetanov, K. A. (9th March 2015). Your brain might not be as "old" as you think. University of Cambridge Research Features. http://www.cam.ac.uk/research/discussion/your-brain-might-not-be-as-old-as-you-think |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.cam.ac.uk/research/discussion/your-brain-might-not-be-as-old-as-you-think |
Description | US congressional delegation |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | For UK-US policy review Enhanced UK-US joint research funding Dialogue on new care models |
Year(s) Of Engagement Activity | 2014 |
Description | Vazquez/Rowe - Fighting PSP both in and outside the lab. PSP Association Magazine (2017) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Vazquez Rodriguez, P. (September 2017). Fighting PSP both in and outside the lab. PSP Association Magazine; raise awareness for PSP |
Year(s) Of Engagement Activity | 2017 |
Description | Voice of Islam - Dementia |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Discussion on voice of islam broadcast on the theme of dementia to raise public awareness, especially within the Muslim community. |
Year(s) Of Engagement Activity | 2022 |
Description | Voice of Islam Radio - Dementia Theme |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Voice of Islam broadcast discussion on dementia. |
Year(s) Of Engagement Activity | 2021 |
Description | WIRED magazine |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Session with WIRED magazine journalists, on cognitive enhancement Education of the public about the ethics, efficacy and evidence for cognitive enhancement |
Year(s) Of Engagement Activity | 2013 |
Description | Wellcome Collection |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | An open evening in central london, with three speakers and audience particpation very positive feedback |
Year(s) Of Engagement Activity | 2012 |
Description | Wolpe - How does the motor system compensate for age-related decline in sensory processing? Cambridge Neuroscience News, UK (2016) |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Wolpe N. (17th October 2016). How does the motor system compensate for age-related decline in sensory processing? Cambridge Neuroscience News, UK. http://www.neuroscience.cam.ac.uk/news/article.php?permalink=bcd0bb401e |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.neuroscience.cam.ac.uk/news/article.php?permalink=bcd0bb401e |